LCG
NARI

Lisanti Capital Growth’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Lisanti Capital Growth’s Portfolio NARI Stock Details NARI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-77,755
Closed -$3.97M – 166
2024
Q4 		$3.97M Buy
+77,755
New +$3.82M 0.95% 48
2024
Q3 		– Sell
-78,200
Closed -$3.77M – 152
2024
Q2 		$3.77M Buy
+78,200
New +$3.47M 0.91% 52
2024
Q1 		– Sell
-33,145
Closed -$2.15M – 158
2023
Q4 		$2.15M Sell
33,145
-66,510
-67% -$4M 0.51% 80
2023
Q3 		$6.52M Buy
+99,655
New +$6.27M 1.03% 38
2023
Q2 		– Sell
-91,630
Closed -$5.66M – 178
2023
Q1 		$5.66M Buy
+91,630
New +$5.5M 0.79% 55
2022
Q4 		– Sell
-55,980
Closed -$4.07M – 167
2022
Q3 		$4.07M Sell
55,980
-40,210
-42% -$2.99M 0.54% 74
2022
Q2 		$6.54M Sell
96,190
-2,135
-2% -$153K 0.89% 47
2022
Q1 		$8.91M Buy
98,325
+16,865
+21% +$1.38M 1% 39
2021
Q4 		$7.43M Buy
+81,460
New +$6.98M 1.08% 34
2021
Q3 		– Sell
-46,035
Closed -$4.29M – 170
2021
Q2 		$4.29M Sell
46,035
-55,941
-55% -$5.42M 0.53% 80
2021
Q1 		$10.9M Buy
101,976
+35,775
+54% +$3.71M 1.4% 19
2020
Q4 		$5.78M Sell
66,201
-27,145
-29% -$1.92M 0.8% 54
2020
Q3 		$6.44M Buy
93,346
+19,466
+26% +$1.25M 1.19% 38
2020
Q2 		$3.58M Buy
+73,880
New +$3.53M 0.73% 71

Other funds holding NARI

SA
SoundView Advisors Olympia, Washington $281M AUM 17.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
TCWM
Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $6.82B AUM 17.15% 1-Year Est. Return

Lisanti Capital Growth's NARI Position: Q1 2025 in Review

Lisanti Capital Growth sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 77,755 shares — an estimated $3.97M sold.

Lisanti Capital Growth first reported a position in NARI in Q2 2020 and held it in 14 quarters. The position peaked at $10.9M in Q1 2021. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • Lisanti Capital Growth reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Lisanti Capital Growth sold 77,755 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $3.97M.
  • Lisanti Capital Growth first reported a position in Inari Medical, Inc. Common Stock in Q2 2020 and held it in 14 quarters.
  • Lisanti Capital Growth's Inari Medical, Inc. Common Stock position peaked at $10.9M in Q1 2021.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on Lisanti Capital Growth's 13F filing for Q1 2025, filed 25 Apr 2025.